What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His main research concerns Cancer research, Pathology, Internal medicine, Immunohistochemistry and Cancer.
Peter Schirmacher has researched Cancer research in several fields, including Carcinogenesis, Gene silencing and Immunology.
The study incorporates disciplines such as Cirrhosis, Hepatitis C, Immune system and Adenocarcinoma in addition to Pathology.
His studies deal with areas such as Gastroenterology, Endocrinology and Oncology as well as Internal medicine.
His work in the fields of Cancer, such as Colorectal cancer, intersects with other areas such as Context.
His studies in Hepatocellular carcinoma integrate themes in fields like RNA and Hepatitis B virus.
His most cited work include:
- EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma (4279 citations)
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development (800 citations)
- Most pancreatic cancer resections are R1 resections. (450 citations)
What are the main themes of his work throughout his whole career to date?
Peter Schirmacher spends much of his time researching Cancer research, Pathology, Internal medicine, Oncology and Cancer.
His Cancer research research incorporates themes from Carcinogenesis, Apoptosis and Immunology.
His Pathology study frequently intersects with other fields, such as Adenocarcinoma.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
He most often published in these fields:
- Cancer research (28.46%)
- Pathology (28.25%)
- Internal medicine (27.06%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (28.46%)
- Internal medicine (27.06%)
- Oncology (12.12%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Internal medicine, Oncology, Pathology and Computational biology.
His Liver cancer and Hepatocellular carcinoma investigations are all subjects of Cancer research research.
His Internal medicine study frequently links to adjacent areas such as Gastroenterology.
Peter Schirmacher works mostly in the field of Oncology, limiting it down to topics relating to Primary tumor and, in certain cases, Malignancy, as a part of the same area of interest.
He studies Immunohistochemistry which is a part of Pathology.
His Computational biology study incorporates themes from Gene panel, In silico and Molecular diagnostics.
Between 2017 and 2021, his most popular works were:
- EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma (4279 citations)
- The 2019 WHO classification of tumours of the digestive system. (299 citations)
- [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. (142 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Peter Schirmacher mostly deals with Internal medicine, Pathology, Cancer research, Oncology and Computational biology.
His Internal medicine research focuses on Gastroenterology and how it connects with Odds ratio.
His Pathology research is multidisciplinary, incorporating elements of KRAS and Molecular pathology.
The concepts of his Cancer research study are interwoven with issues in Gene expression profiling, Immune system, Immunotherapy, DNA mismatch repair and RNA interference.
His Immunotherapy study which covers Tumor necrosis factor alpha that intersects with Hepatocellular carcinoma.
His Oncology research includes themes of Tyrosine kinase, Primary tumor and DNA profiling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
